Your search returned 11 results.

Sort
Results
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial. [electronic resource] by
Producer: 20210216 In: JAMA neurology vol. 77
Availability: No items available.